Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ENCOMPASS FAMILY AND INTERNAL MEDICINE GROUP INC

NPI: 1033449640 · LA MESA, CA 91942 · Geriatric Medicine (Family Medicine) Physician · NPI assigned 01/04/2010

$33K
Total Medicaid Paid
11,933
Total Claims
9,462
Beneficiaries
35
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialLAJVARDI, ROBERT (OWNER)
NPI Enumeration Date01/04/2010

Related Entities

Other providers sharing the same authorized official: LAJVARDI, ROBERT

ProviderCityStateTotal Paid
BIRDROCK SAN DIEGO CA $3.16M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 765 $5K
2019 1,301 $9K
2020 6,184 $6K
2021 2,098 $5K
2022 513 $5K
2023 470 $2K
2024 602 $636.48

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,092 2,493 $30K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 2,893 2,135 $2K
99490 Ccm add 20min 52 52 $724.96
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 612 447 $123.87
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 263 227 $59.20
99215 Prolong outpt/office vis 43 40 $51.48
82670 172 135 $41.91
82627 153 120 $33.36
83001 168 132 $27.87
80061 Lipid panel 307 266 $26.80
84403 86 66 $25.82
84443 Thyroid stimulating hormone (TSH) 198 163 $25.20
82533 153 120 $24.45
82607 197 162 $22.62
82746 158 123 $22.05
84270 170 135 $21.74
84144 170 135 $20.86
82728 159 124 $20.46
84146 126 103 $19.38
83002 168 132 $18.52
80053 Comprehensive metabolic panel 340 296 $15.84
84480 141 117 $14.18
86141 153 120 $12.96
83525 154 121 $11.44
83036 Hemoglobin; glycosylated (A1C) 221 181 $9.72
84439 169 135 $9.02
85025 Blood count; complete (CBC), automated, and automated differential WBC count 205 169 $7.78
83735 167 133 $6.70
83540 157 124 $6.48
84100 151 118 $4.74
84550 153 120 $4.52
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 455 423 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 85 68 $0.00
84153 19 15 $0.00
83090 23 12 $0.00